Indegene Ltd.

NSE: INDGN | BSE: 544172 | ISIN: INE065X01017 | Industry: Healthcare Services
| Mid-range Performer

logo
Indegene Ltd.
03 May 2024
578.95
2.04%
HDFC Securities
IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products
Indegene Ltd. has an average target of 603.33 from 3 brokers.
More from Indegene Ltd.
Recommended